InvestorsHub Logo
icon url

jessellivermore

04/15/20 10:21 AM

#266350 RE: SBsandman #266346

SB....

"Why would generics settle for a sliver of the pie (1/100), when they are staring down at the whole damn thing with a big toothy grin?"

The court might decide for them...

The current decision is not fair and equitable and will infringe on Amarin's patents.

":>) JL



icon url

anfla

04/15/20 10:30 AM

#266359 RE: SBsandman #266346

The generics individually have not really that much to gain as people would think. If 5-10 companies launch in a much smaller market without Amarin growing its size first and at a cheaper price, you’re talking about $50-100M sales each annually max at a low margin.